| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
298,146,911 | 281,692,181 | 162,345,165 | 113,758,594 | 84,822,504 |
| Cost of Revenue
|
-293,730,477 | -276,612,363 | -158,420,035 | -110,874,297 | -81,671,652 |
|
Gross Profit
|
4,416,435 | 5,079,818 | 3,925,129 | 2,884,297 | 3,150,852 |
|
Operating Income/Expenses
|
-2,695,929 | -2,634,208 | -2,507,337 | -2,520,519 | -2,355,969 |
|
Total Operating Profit/Loss
|
1,720,506 | 2,445,610 | 1,417,792 | 363,778 | 794,883 |
| Total Net Finance Income/Expense
|
-46,898 | -39,737 | -19,456 | -15,016 | -11,395 |
| Net Investment Income
|
14,005 | 8,721 | -45,933 | 39,420 | 0 |
| Irregular Income/Expenses
|
-3,385 | -4,033 | 11,314 | -10,893 | -296,511 |
|
Other Income/Expense, Non-Operating
|
-111,109 | -124,743 | -125,271 | -137,783 | -136,885 |
|
Non-Operating Income/Expenses, Total
|
-147,387 | -159,792 | -179,346 | -124,272 | -444,791 |
|
Pretax Income
|
1,573,120 | 2,285,819 | 1,238,446 | 239,505 | 350,090 |
| Provision for Income Tax
|
-774,677 | -772,113 | -19,725 | -20,877 | 48,256 |
|
Net Income from Continuing Operations
|
798,443 | 1,513,706 | 1,218,721 | 218,628 | 398,346 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
798,442 | 1,513,705 | 1,218,720 | 218,628 | 398,347 |
|
Net Income after Non-Controlling/Minority Interests
|
798,442 | 1,513,705 | 1,218,720 | 218,628 | 398,347 |
|
Net Income Available to Common Stockholders
|
798,442 | 1,513,705 | 1,218,720 | 218,628 | 398,347 |
|
Diluted Net Income Available to Common Stockholders
|
798,442 | 1,513,705 | 1,218,720 | 218,628 | 398,347 |
| Basic EPS
|
65.93 | 105.14 | 84.57 | 15.20 | 27.60 |
| Diluted EPS
|
65.84 | 105.05 | 84.57 | 15.17 | 27.60 |
|
Basic Weighted Average Shares Outstanding
|
14,385.16 | 14,396 | 14,410 | 14,383.42 | 14,432.86 |
|
Diluted Weighted Average Shares Outstanding
|
14,398.36 | 14,409.20 | 14,410.52 | 14,410.70 | 14,432.86 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,620,018 | 2,325,556 | 1,257,902 | 254,521 | 361,485 |
|
EBITDA
|
2,442,136 | 2,442,136 | 1,376,747 | 318,945 | 462,682 |
|
Normalized EBITDA
|
2,437,448 | 2,437,448 | 1,413,242 | 290,488 | 759,193 |
|
Normalized Income
|
801,042.68 | 2,289,852 | 1,238,300 | 251,518 | 648,752 |
|
Total Unusual Items
|
3,385 | -4,688 | 36,495 | -28,457 | 296,511 |
|
Total Unusual Items Excluding Goodwill
|
3,385 | -4,688 | 36,495 | -28,457 | 296,511 |
|
Tax Effect of Unusual Items
|
785.32 | -1,583.53 | 580.27 | -2,481.45 | 68,790.55 |
|
Tax Rate, Calculated
|
0.23 | 0.34 | 0.02 | 0.09 | 0.23 |
3/31/2023 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade